期刊文献+

儿童单纯口服咪达唑仑的药代动力学 被引量:8

下载PDF
导出
摘要 咪达唑仑是一种具有抗焦虑、镇静、催眠、中枢性肌肉松弛及顺行性遗忘作用的苯二氮卓类药物,口服给药便捷有效,小儿更易于接受[1]。国外咪达唑仑商品主要有Dormicum、Versed等,剂型有注射液、糖浆和片剂;国内商品主要为力月西,剂型有注射液和片剂。
作者 侯雪莹 万阔
出处 《协和医学杂志》 2016年第4期300-302,共3页 Medical Journal of Peking Union Medical College Hospital
  • 相关文献

参考文献18

  • 1王燮,谭玲,姚玉笙.咪达唑仑应用于小儿术前镇静的研究进展[J].华西医学,2014,29(6):1178-1181. 被引量:10
  • 2Pacifici GM. Clinical pharmacology of midazolam in neonatesand children: effect of disease-a review [J]. Int J Pediatr,2014, 2014: 309342.
  • 3张锦,丁平田,邱峰,肇丽梅.高效液相色谱法测定术前儿童口服复方氯胺酮的血药浓度[J].中国临床药理学杂志,2005,21(1):50-53. 被引量:4
  • 4de Wildt SN, Kearns GL, Hop WC, et al. Pharmacoineticsand metabolism of oral midazolam in preterm infants [J]. BrJ Clin Pharmacol, 2002, 53: 390-392.
  • 5de Wildt SN, Kearns GL, Murry DJ, et al. Ontogeny of midazolamglucuronidation in preterm infants [J]. Eur J ClinPharmacol, 2010, 66: 165-170.
  • 6US Food and Drug Administration. General clinical pharmacologyconsidertations for pediatric studies for drugs and biologicalproducts [S/OL]. ( 2014-12-09 ). http://www.federalregister. gov/articles/2014/12/09/2014-28716/general-clinical-pharmacology-considerations-for-pediatrics-studiesfor-drugs-and-bioligical-products.
  • 7Reed MD, Rodarte A, Blumer JL, et al. The single-dosepharmacokinetics of midazolam and its primary metabolite inpediatric patients after oral and intravenous administration[J]. J Clin Pharmacol, 2001, 41: 1359-1369.
  • 8王洪允,陈霞,江骥,等.年龄和性别对于咪达唑仑药代动力学特征的影响:中国药学会药物临床评价研究专业委员会2015年学术年会会刊[C/0L] .北京:中国药学会,2015. http://cpfd. cnki. com. cn/Article/CPFDTOTALYYWS201507001032.htm.
  • 9Payne K, Mattheyse FJ, Liebenberg D, et al. The pharmacokineticsof midazolam in paediatric patients [J]. Eur J ClinPharmacol, 1989, 37: 267-272.
  • 10Malinovsky JM, Populaire C, Cozian A, et al. Premedicationwith midazolam in children. Effect of intranasal, rectal andoral routes on plasma midazolam concentrations [J]. Anaesthesia,1995, 50: 351-354.

二级参考文献42

  • 1Bolon M, Boulieu R, Flamens C, et al. Sedation induced by midazolam in intensive care: pharmacologic and pharmacokinetic aspects[J]. Ann Fr Anesth Reanim, 2002, 21 (6):478.
  • 2Krupka E, Venisse N, Lafay C, et al. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers[J].Eur J Clin Pharmacol, 2006,62 (8) : 653.
  • 3He P, Court MH, Greenblatt D J, et al. Factors influencing midazolam hydroxylation activity in human liver microsomes[J].Drug Metab Dispos, 2006,34 ( 7 ) : 1 198.
  • 4Leucuta SE, Vlase L. Pharmacokinetics and metabolic drug interactions[J].Current Clinical Pharmacology, 2006, 1 (1):5.
  • 5Belle D J, Callaghan JT, Gorski JC, et al.The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity[J]. Br J Clin Pharmacol, 2002, 53(1):67.
  • 6Metsugi Y, Miyaji Y, Ogawara K, et al.Appearanee of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function[J]. Pharm Res, 2008,25 (4) : 886.
  • 7Funk W,Jakob W,Riedl T,et al.Oral preanaesthetic medication for children: double-blind randomized study of a combination of midazolam and ketamine vs midazolam or ketamine alone [J].Br J Anaesth,2000; 84:335-340.
  • 8Warner DL,Cabaret J,Velling D.Ketamine plus midazolam ,A mosteffective paediatric premedicant [J].Paediatr Anaesth,1995; 5:293-295.
  • 9Malinovsky JM,Populaire C,Cozian A,et,al.Premedication with midazolam in children.Effect of intranasal,rectal and oral routes on plasma midazolam concentrations [J].Anaesthesia,1995; 50: 351-354.
  • 10Malinovsky JM,Servin F,Cozian A,et al.Ketamine and norketamine plasma concentrations after iv,nasal and rectal administration in children[J].Br JAnesth,1996;77:203 -207.

共引文献15

同被引文献55

引证文献8

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部